AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Universitaire, Amiens
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute kidney injury (AKI) is a frequent disease in conventional hospital departments and in intensive care units. It's associated with a high risk to develop chronic kidney disease (CKD), even after a single small AKI episode. It's also associated with an important morbi-mortality, particularly cardiovascular (CV). Some studies have already showed a link between AKI and CV risk but pathologic mechanisms implicated are still unknown. In AKI and CKD, numerous substances, called uremic toxins (UT) are accumulating in blood. In CKD, those toxins, and particularly Indoxyl sulfate (IS), are known to have cardiac and vascular deleterious consequences. However, in AKI, whether acute accumulation of UT may trigger CV complications is unknown. The purpose of this study is that during AKI, a high UT concentration, in particular IS, would be associated with early vascular and cardiac dysfunctions t

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age over 18 years old. * Patients hospitalized in conventional hospital departments and in intensive care units of nephrology. * Patients with moderate to severe AKI (KDIGO 2 or 3) without dialysis. * AKI from functional or organic aetiology Exclusion Criteria: * Patients with severe CKD (GFR\<45ml/min/1.73 m2) or with kidney transplants. * Patients with AKI from septic or obstructive aetiology. * Patients with AKI from toxic aetiology whose toxic would be also responsable of cardia toxicity. * Patients with sepsis or blood inflammation. * Patients with severe chronic cardia dysfunction. * Patients with arrhythmia or complete heart block. * Patients with peripheral artery occlusive disease. * Pregnancy. * Patients on palliative care.
๐Ÿ’Š

What it tests

  • blood sample
๐Ÿ“

Where

1 site
Amiens hospital
Amiens, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy